Featured
Last news
At least 10 dead in Colombia landslide
A landslide triggered by heavy rains killed at least 10 people and injured eight others Tuesday near the Colombian city of Medellin, government officials said.
This Summer, ST(ripped) is the Self-Love Bestseller We've Been Waiting For
DENVER, CO / ACCESS Newswire / June 25, 2025 / 'Who are you, anyway?' is the question that opens bestselling author Niccole Hendrickson's debut book this summer, setting the stage for a transformative and soul-searching journey where she invites women to strip away the roles, rules, and regrets that have kept them small. ST(ripped): A Story of Shedding, Shifting, Shining, and Finding Strength isn't just a memoir, but a beacon of hope urging you to return to yourself. For every woman ready to shed what no longer serves them, shift into alignment, and shine unapologetically, this is your invitation to rise, reclaim your voice, and write the most powerful story of all: your own.
New to The Street Breaks Interview Records with Global Icons KITON, Goldman Sachs (NYSE: GS), Ford Motors (NYSE: F), and IMG Academy via Merrill Lynch (NYSE: BAC)
KITON Segment Surpasses 1 Million Views as New to The Street Continues to Dominate Financial Media Across Broadcast, Digital, and Outdoor Platforms
iTolerance, Inc. Appoints Former FDA Senior Executive Wayne Pines to the Board of Directors
MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced the appointment of Wayne Pines to the Company's Board of Directors. Mr. Pines has served as a member of the Company's Strategic Advisory Board since 2023.
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogsJaguar is exploring the possibility of approval of Canalevia for treatment of general diarrhea in dogs in the EU based on the statistically significant data from a completed studyDiarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogsCompany strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia to regulatory approval and commercialization for general diarrhea globally
MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects
MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced new in vitro preclinical data generated by Eurofins supporting the therapeutic potential of SKNY-1, a next-generation oral drug candidate being developed by SKNY Pharmaceuticals, Inc. ("SKNY"). MIRA has signed a definitive agreement to acquire SKNY, and the proposed transaction remains subject to regulatory review and shareholder approval.
Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split
Reverse Split Becomes Effective Friday, June 27, 2025Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem
TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.
US judge backs using copyrighted books to train AI
A US federal judge has sided with Anthropic regarding training its artificial intelligence models on copyrighted books without authors' permission, a decision with the potential to set a major legal precedent in AI deployment.
US judge allows using pirated books to train AI
A federal judge has sided with the AI company Anthropic in its practice of training a chatbot on copyrighted books without permission from the authors.
French volunteers hand migrants water beyond the crowded beach
Many others had rushed to the beach to cool off in the heat, but French retiree Sylvie Baudelet and another volunteer were busy handing out water, tea and coffee to thirsty migrants.
France ordered to compensate family of jogger killed by toxic algae
A French court on Tuesday ordered the state to compensate the family of a 50-year-old man who died in 2016 during a run after inhaling poisonous gas emitted by rotting green algae piled along the country's western coast.
France charges Briton over staged Disneyland 'marriage' with child
France charged a British citizen with offences including money-laundering and identity theft after he allegedly organised a bizarre ceremony at Disneyland Paris where he played the role of the groom in a fake marriage with a nine-year-old girl, prosecutors said Tuesday.
Brazil records 62% jump in area burned by forest fires: monitor
Historic forest fires in Brazil last year scorched through an area larger than the size of Italy, recording a burned area some 60 percent higher than average of the last four decades, said a report released Tuesday.
Vietnam puts 41 on trial in $45 mn corruption case
A $45 million corruption trial against 41 people including state officials began in Vietnam on Tuesday, part of the communist state's wide-ranging anti-graft drive.
Trial of Sean Combs approaches final stretch
The high-profile trial of Sean "Diddy" Combs is approaching its final stretch, with both teams poised to rest their cases as soon as Tuesday.
Judge tells Australian mushroom murder jury to put emotion aside
Jury members in the trial of an Australian woman accused of murdering three relatives with a toxic mushroom-laced meal were warned Tuesday to cast aside any "prejudice and sympathy".
Glamour, gripes as celebs head to Venice for exclusive Bezos wedding
Celebrities in superyachts sail into Venice this week for the three-day wedding party of Amazon tycoon Jeff Bezos and Lauren Sanchez, despite irate locals who say the UNESCO city is no billionaire's playground.
Pro-Palestinian protest leader details 104 days spent in US custody
Mahmoud Khalil, one of the most prominent leaders of pro-Palestinian protests on US campuses, recounted his experience surviving 104 days in Immigration and Customs Enforcement detention after being targeted for deportation by the Trump administration.
Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026
Company's CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing
Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025
Ambience Healthcare's "Patient Recap" Offers Clinicians the First Chart Summarization Technology from an Ambient AI Platform
An industry first: Ambience Healthcare becomes the only ambient AI to deliver comprehensive patient context before encounters, extending beyond documentation to clinical workflow transformation
Brij Secures $8M in Oversubscribed Round to Power the Future of Offline-to-Online Customer Relationships
Trusted by 150 leading brands globally, the agentic AI-powered platform converts third-party retail transactions into direct, data-driven connections.
US Supreme Court allows third country deportations to resume
A divided US Supreme Court paved the way on Monday for the Trump administration to resume deportations of undocumented migrants to countries that are not their own.
Top US court takes case of Rastafarian whose hair was cut in prison
The US Supreme Court agreed on Monday to hear the case of a devout Rastafarian whose knee-length dreadlocks were forcibly shorn while he was in prison in the southern state of Louisiana.
Syria president vows those involved in church attack will face justice
Syrian leader Ahmed al-Sharaa vowed Monday that those involved in a "heinous" suicide attack on a Damascus church would face justice, as he called for unity in the diverse, multi-faith country.
In Norway's Arctic, meteorologists have a first-row seat to climate change
In the cold of the Norwegian Arctic, meteorologist Trond Robertsen manually recorded precipitation levels for over two decades, witnessing firsthand the effects of climate change.
Suicide attack on Damascus church kills at least 22
A shooting and suicide bombing at a Damascus church during a packed service on Sunday killed at least 22 people, authorities said, blaming a member of the Islamic State group for the unprecedented attack.
French police probe fake Disneyland 'marriage' with nine-year-old
French police were on Sunday probing the circumstances of a bizarre stunt at Disneyland outside of Paris, with a group of adults suspected of hiring the theme park and paying hundreds of extras to stage a fake marriage for a nine-year-old Ukrainian girl.
Basatne MENA and Likewize Launch Region's First Subscription-Based Handset Program: "Upgrade & Protect"
Designed to combine sustainability, flexibility, and seamless user experience.
Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer
Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25%As recently announced, initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expectedCompany strategy: Seek business development partnerships for license to develop and commercialize Jaguar's intestinal failure products, resulting in non-dilutive funding for Jaguar
LQR House Announces Upcoming Strategic Marketing Collaboration With Whiplash Whiskey Ahead of Summer Launch
MIAMI BEACH, FL / ACCESS Newswire / June 23, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, is pleased to announce a new marketing agreement with Whiplash Whiskey. Under the agreement, LQR House will launch a custom digital multi-platform marketing campaign. Such campaign is intended to support the summer debut of Whiplash's latest product - a whipped cream-flavored whiskey.